Results 71 to 80 of about 262 (112)
Gastric perforation after duodenopancreatectomy. [PDF]
Bäcker H +3 more
europepmc +1 more source
In vitro antifungal susceptibilities of six antifungal drugs against clinical Candida glabrata isolates according to EUCAST. [PDF]
Fatahinia M +4 more
europepmc +1 more source
Second allogeneic transplantation in relapsed acute leukemia - a risk worth taking? [PDF]
Zielińska P +12 more
europepmc +1 more source
[Management of side effects of CAR T cells]. [PDF]
Bach F +3 more
europepmc +1 more source
[Visual diagnosis for experts]. [PDF]
Arheilger L +6 more
europepmc +1 more source
Mucormycosis, COVID-19 and Acute Lymphoid Leukemia: Case Report
Cordero-Hernández EL +5 more
europepmc +1 more source
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic Fibrosis. [PDF]
Naehrig S +12 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs of Today, 2005
Invasive fungal infections are occurring with increasing frequency secondary to medical advances in the areas of transplantation, cancer management and autoimmune diseases. Unfortunately, the currently available antifungal armamentarium does not meet the increasing needs of managing infection in these complex patient populations.
Elizabeth S, Dodds Ashley +1 more
openaire +4 more sources
Invasive fungal infections are occurring with increasing frequency secondary to medical advances in the areas of transplantation, cancer management and autoimmune diseases. Unfortunately, the currently available antifungal armamentarium does not meet the increasing needs of managing infection in these complex patient populations.
Elizabeth S, Dodds Ashley +1 more
openaire +4 more sources
Expert Opinion on Drug Safety, 2013
The increasing number of invasive fungal infections (IFI) among immunocompromised hosts is a significant clinical issue. Diagnosis of IFI, choosing among the available antifungal drugs, and the high morbidity/mortality associated with IFI pose clinical challenges for healthcare providers.
Pauline L, Jacinto +1 more
openaire +2 more sources
The increasing number of invasive fungal infections (IFI) among immunocompromised hosts is a significant clinical issue. Diagnosis of IFI, choosing among the available antifungal drugs, and the high morbidity/mortality associated with IFI pose clinical challenges for healthcare providers.
Pauline L, Jacinto +1 more
openaire +2 more sources

